MaaT Pharma
A clinical-stage biotech developing microbiome-based therapeutics for oncology.
MAAT | PA
Overview
Corporate Details
- ISIN(s):
- FR0012634822 (+1 more)
- LEI:
- 969500CQQB6XUNW6CN97
- Country:
- France
- Address:
- 70 AVENUE TONY GARNIER, 69007 LYON
- Website:
- https://www.maatpharma.com/
Description
MaaT Pharma is a clinical-stage biotechnology company specializing in the development of microbiome-based therapeutics. The company's primary focus is on oncology, aiming to improve survival outcomes for cancer patients by modulating the immune system through the gut microbiome. It develops Microbiome Ecosystem Therapies (MET) designed to restore gut microbiome symbiosis. The company's pipeline includes product candidates for treating complications in patients with blood cancers and solid tumors, with its lead candidate, MaaT013, in late-stage development for acute Graft-versus-Host Disease (aGvHD). MaaT Pharma utilizes an AI-powered platform for drug development and has its own cGMP manufacturing capabilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-21 18:00 |
Inside Information / Other news releases
|
English | 124.4 KB | ||
| 2025-01-21 18:00 |
Informations privilégiées / Autres communiqués
|
French | 152.4 KB | ||
| 2025-01-08 19:30 |
Informations privilégiées / Autres communiqués
|
French | 184.1 KB | ||
| 2025-01-08 19:30 |
Inside Information / Other news releases
|
English | 205.6 KB | ||
| 2025-01-07 18:00 |
Total number of voting rights and capital / Information on the total number of …
|
English | 76.3 KB | ||
| 2025-01-07 18:00 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 131.8 KB | ||
| 2024-12-10 02:30 |
Informations privilégiées / Autres communiqués
|
French | 903.8 KB | ||
| 2024-12-10 02:30 |
Inside Information / Other news releases
|
English | 817.8 KB | ||
| 2024-12-09 18:00 |
Inside Information / Other news releases
|
English | 108.1 KB | ||
| 2024-12-09 18:00 |
Informations privilégiées / Autres communiqués
|
French | 886.1 KB | ||
| 2024-12-05 18:00 |
Inside Information / Other news releases
|
English | 129.5 KB | ||
| 2024-12-05 18:00 |
Informations privilégiées / Autres communiqués
|
French | 748.6 KB | ||
| 2024-11-26 07:30 |
Inside Information / Other news releases
|
English | 149.6 KB | ||
| 2024-11-26 07:30 |
Informations privilégiées / Autres communiqués
|
French | 151.6 KB | ||
| 2024-11-07 07:30 |
Inside Information / Other news releases
|
English | 111.2 KB |
Automate Your Workflow. Get a real-time feed of all MaaT Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MaaT Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MaaT Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-12 | N/A | Other | Sell | 8 | 60.87 EUR |
| 2024-07-11 | N/A | Other | Sell | 57 | 436.14 EUR |
| 2023-12-22 | N/A | Other | Buy | 2,940 | 14,994.00 EUR |
| 2023-12-22 | N/A | Other | Buy | 1,960 | 9,996.00 EUR |
| 2023-09-27 | N/A | Other | Buy | 500 | 3,050.00 EUR |
Peer Companies
